Apixaban Export Market Intelligence: India's 171 Suppliers Shipping to 98 Countries — TransData Nexus 2026

Q: Who are the top apixaban exporters from India?

The top apixaban exporters from India are: 1. MACLEODS PHARMACEUTICALS LTD — $87.5M (48.6% market share); 2. APOTEX RESEARCH PRIVATE LIMITED — $20.6M (11.4% market share); 3. INTAS PHARMACEUTICALS LIMITED — $18.7M (10.4% market share); 4. SANDOZ PRIVATE LIMITED — $15.6M (8.7% market share); 5. ZYDUS LIFESCIENCES LIMITED — $8.1M (4.5% market share). Together they account for 83.6% of India's total apixaban export value.

Q: What is the total export value of apixaban from India?

The total export value of apixaban from India is $179.9M USD, recorded across 4,492 shipment transactions from 171 active exporters to 98 destination countries. The average shipment value is $40.1K.

Q: Which countries import apixaban from India?

India exports apixaban to 98 countries worldwide. The top importing countries are: LEBANON (41.8% share, $75.1M), CANADA (18.3% share, $33.0M), BRAZIL (7.8% share, $14.1M), COLOMBIA (7.4% share, $13.4M), MALTA (7.3% share, $13.2M). These five markets account for 82.7% of total export value.

Q: What is the HS code for apixaban exports from India?

The primary HS code for apixaban exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of apixaban exports from India?

The average unit price for apixaban exports from India is $6.90 USD per unit, with prices ranging from $0.01 to $4444.44 depending on formulation, packaging, and order volume. The total market is valued at $179.9M across 4,492 shipments.

Q: Which ports handle apixaban exports from India?

The primary ports for apixaban exports from India are SAHAR AIR (16.1% of shipments), SAHAR AIR CARGO ACC (INBOM4) (15.0% of shipments), DELHI AIR CARGO ACC (INDEL4) (13.5% of shipments), DELHI AIR (8.1% of shipments), MUNDRA SEA (3.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of apixaban?

India is one of the world's leading exporters of apixaban due to its large base of 171 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports apixaban to 98 countries, demonstrating 50% global market coverage.

Q: What certifications do Indian apixaban exporters need?

Indian apixaban exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import apixaban from India?

There are 371 registered buyers importing apixaban from India, spread across 98 countries. The repeat buyer rate is 75.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top apixaban supplier from India?

MACLEODS PHARMACEUTICALS LTD is the leading apixaban exporter from India with a market share of 48.6% and total export value of $87.5M across 85 shipments. The top 5 suppliers together control 83.6% of total export value.

Suresh Sormare

Apixaban

India Pharmaceutical Trade Intelligence

$179.9M171 Suppliers98 CountriesHS 30049099

ExportsIndia → LEBANON41.8%India → CANADA18.3%

ImportsGERMANY → India$14.0B BELGIUM → India$17.4M

Apixaban Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Apixaban to the World

Between 2022 and 2026, India exported $179.9M worth of apixaban across 4,492 verified shipments to 98 countries — covering 50% of world markets in the Cardiovascular segment. The largest destination is LEBANON (41.8%). MACLEODS PHARMACEUTICALS LTD leads with a 48.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Apixaban export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Apixaban export data snapshot — $179.9M · 171 exporters · 98 countriesTransData Nexus · Indian Customs Data

Top Apixaban Exporters from India

171 active exporters · Ranked by export value

View all 171 →

Top Apixaban Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MACLEODS PHARMACEUTICALS LTD	$87.5M	85	9	48.6%
2	APOTEX RESEARCH PRIVATE LIMITED

Top Countries Importing Apixaban from India

98 destination markets · Ranked by import value

All 98 countries →

Top Countries Importing Apixaban from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	LEBANON	$75.1M	41.8%
2	CANADA	$33.0M	18.3%
3	BRAZIL	$14.1M	7.8%
4	COLOMBIA	$13.4M	7.4%
5	MALTA	$13.2M	7.3%
6	NETHERLANDS	$11.9M	6.6%
7	UNITED KINGDOM	$4.1M	2.3%
8	MAURITIUS	$2.7M	1.5%
9	SAUDI ARABIA	$2.5M	1.4%
10	PHILIPPINES	$2.1M	1.2%

LEBANON is India's largest apixaban export destination, absorbing 41.8% of total exports worth $75.1M. The top 5 importing countries — LEBANON, CANADA, BRAZIL, COLOMBIA, MALTA — together account for 82.7% of India's total apixaban export value. The remaining 93 destination countries collectively receive the other 17.3%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Apixaban to India?

27 origin countries · Total import value: $14.0B

India imports apixaban from 27 countries with a combined import value of $14.0B. The largest supplier is GERMANY ($14.0B, 68 shipments), followed by BELGIUM and IRELAND. All values are from Indian Customs (DGFT) import records.

Countries Supplying Apixaban to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$14.0B	68	99.9%
2	BELGIUM	$17.4M	7	0.1%
3	IRELAND	$2.1M	13	0.0%
4	UNITED STATES	$70.5K	43	0.0%
5	SWITZERLAND	$41.1K	2	0.0%
6	RUSSIA	$12.1K	3	0.0%
7	ITALY	$10.5K	2	0.0%
8	BRAZIL	$8.5K	7	0.0%
9	CHINA	$6.0K	6	0.0%
10	MALTA	$5.6K	11	0.0%

Showing top 10 of 27 origin countries

GERMANY is the largest supplier of apixaban to India, accounting for 99.9% of total import value. The top 5 origin countries — GERMANY, BELGIUM, IRELAND, UNITED STATES, SWITZERLAND — together supply 100.0% of India's apixaban imports. Click any country to see detailed supplier and buyer data for that import corridor.

Apixaban — Export Intelligence Video

Visual overview of India's apixaban import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's apixaban pharmaceutical import and export market — $179.9M in total trade, 171 verified manufacturers, and 98 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Apixaban

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the FDA Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for Apixaban, indicating a competitive generic market in the United States. Recent approvals include those granted in January 2026, reflecting ongoing interest in Apixaban's therapeutic applications. The regulatory pathway for Apixaban involves demonstrating bioequivalence to the reference listed drug, Eliquis, and compliance with Current Good Manufacturing Practices (cGMP). Given the presence of 171 active Indian exporters, it is imperative for manufacturers to ensure adherence to FDA regulations to maintain market access and avoid potential import alerts.

2EU & UK Regulatory Framework

In the European Union, Apixaban is marketed under the brand name Eliquis, with marketing authorization granted by the European Medicines Agency (EMA) in May 2011. Generic versions, such as Apixaban Accord, received EMA approval in July 2020. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) continues to recognize these authorizations post-Brexit. Manufacturers exporting to the EU and UK must comply with EU Good Manufacturing Practice (GMP) guidelines, which encompass stringent quality control measures and regular inspections to ensure product safety and efficacy.

3WHO Essential Medicines & Global Standards

Apixaban is included in the 22nd edition of the WHO Model List of Essential Medicines, underscoring its importance in global health. While specific WHO Prequalification for Apixaban is not documented, adherence to international pharmacopoeia standards—such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP)—is crucial for manufacturers to ensure global acceptance and compliance with quality standards.

4India Regulatory Classification

In India, Apixaban is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensation. The National Pharmaceutical Pricing Authority (NPPA) has not imposed a ceiling price on Apixaban as of March 2026, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and to monitor the quality of pharmaceutical exports.

5Patent & Exclusivity Status

The primary patent for Apixaban expired in December 2019, leading to increased generic competition globally. This has facilitated the entry of multiple manufacturers into the market, contributing to the substantial export figures from India.

6Recent Industry Developments

In May 2024, the EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending an extension of the marketing authorization for Eliquis to include pediatric indications, specifically for the treatment and prevention of venous thromboembolism (VTE) in children aged 28 days to less than 18 years. (ema.europa.eu)

In November 2023, the CHMP recommended the removal of a pharmaceutical form (powder and solvent for oral solution) and a change to an existing indication for the use of Pradaxa in children under 18 years of age. (ema.europa.eu)

These developments reflect the dynamic regulatory landscape for anticoagulants like Apixaban, emphasizing the need for manufacturers to stay informed and compliant with evolving international standards and approvals.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Apixaban

Retail & reference prices across 9 markets vs. India FOB export price of $6.90/unit

Global Price Benchmark for Apixaban across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$10	USD	According to the FDA's Orange Book, Apixaban is approved for use in the United States.
United Kingdom	$2.60	GBP	As per the NHS Drug Tariff, Apixaban is listed for reimbursement.
Germany	$2.75	EUR	The European Medicines Agency (EMA) has authorized the use of Apixaban in Germany.
Australia	$2.10	AUD

Supply Chain Risk Assessment — Apixaban

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Apixaban, a widely used anticoagulant, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a dominant player in this sector. This dependency poses a significant risk, as any disruption in the supply chain from China can directly impact the availability of Apixaban APIs in India.

Recent geopolitical tensions have exacerbated these risks. For instance, the closure of the Strait of Hormuz in March 2026 disrupted the supply of raw materials to Asia's petrochemical industry, leading to production cutbacks and force majeure declarations. Such events highlight the vulnerability of the pharmaceutical supply chain to geopolitical disruptions, emphasizing the need for diversification and resilience in sourcing strategies.

2Supplier Concentration & Single-Source Risk

The export market for Apixaban from India is highly concentrated, with the top five exporters accounting for 83.6% of the total export value. MACLEODS PHARMACEUTICALS LTD alone holds a 48.6% share, amounting to $87.5 million USD. This high level of supplier concentration increases the risk of supply chain disruptions, as any operational issues within these key companies can significantly impact global Apixaban availability.

Access Complete Apixaban Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,492 transactions across 98 markets.

Request Demo View Pricing

Frequently Asked Questions — Apixaban Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top apixaban exporters from India?

The leading apixaban exporters from India are MACLEODS PHARMACEUTICALS LTD, APOTEX RESEARCH PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, and 12 others. MACLEODS PHARMACEUTICALS LTD leads with 48.6% market share ($87.5M). The top 5 suppliers together control 83.6% of total export value.

What is the total export value of apixaban from India?

The total export value of apixaban from India is $179.9M, recorded across 4,492 shipments from 171 active exporters to 98 countries. The average shipment value is $40.1K.

Which countries import apixaban from India?

India exports apixaban to 98 countries. The top importing countries are LEBANON (41.8%), CANADA (18.3%), BRAZIL (7.8%), COLOMBIA (7.4%), MALTA (7.3%), which together account for 82.7% of total export value.

What is the HS code for apixaban exports from India?

The primary HS code for apixaban exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Apixaban

Apixaban

Top Apixaban Exporters from India

Top Countries Importing Apixaban from India

Who Supplies Apixaban to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Apixaban — Export Intelligence Video

Regulatory Landscape — Apixaban

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Apixaban

Supply Chain Risk Assessment — Apixaban

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Apixaban Trade Intelligence

Frequently Asked Questions — Apixaban Exports from India

Who are the top apixaban exporters from India?

What is the total export value of apixaban from India?

Which countries import apixaban from India?

What is the HS code for apixaban exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of apixaban exports from India?

Which ports handle apixaban exports from India?

Why is India a leading exporter of apixaban?

What certifications do Indian apixaban exporters need?

How many buyers import apixaban from India?

What is the market share of the top apixaban exporter from India?

Analysis Methodology